From MedicalVoices.org (November 16, 2009):

Truth Times Two: The Cervical Cancer (HPV) and Swine Flu Vaccines
Erika Schwartz, MD [USA] [Host: Mayer Eisenstein, MD, JD, MPH]

Dr. Schwartz will present on the HPV and swine flu (2009 H1N1) vaccines. Dr. Schwartz is a leading national expert on wellness and true disease prevention. She has authored four best-selling books, is an Extra TV Lifechanger, bylined in the Wall Street Journal, and international speaker and TV personality.

A cum laude graduate, AOA honor society member from SUNY- Downstate College of Medicine, Dr. Schwartz is trained at Kings County Hospital Center in Brooklyn, NY in Internal Medicine and Critical Care. Upon completion of her postgraduate training, at the age of 28, Dr. Erika became the first woman and youngest doctor to be named Director of Emergency Medicine at Westchester County Medical Center- New York Medical College in Valhalla, NY.

Since the start of her distinguished career, Dr. Erika has been committed to empowering patients and teaching physicians compassion alongside with scientific and clinical information. Dr. Erika has lectured at Harvard, authored the seminal article on the use of hormones in wellness and disease prevention in the prestigious peer reviewed publication Medical Clinics. She is a founding director of the not for profit Bioidentical Hormone Initiative and a senior faculty member of the Bioidentical Hormone Institute. Dr. Erika maintains a private practice in New York City.

Please click here to view the webinar.

Please go to Medical Voices and Dr. Bloem’s Videos Page to view more information on this topic.

From NaturalNews.com:

From the United States to New Zealand and all other countries around the world people are concerned about Gardasil, the vaccine for HPV (human papilloma virus), misleading research and marketing, and forced vaccination programs.

Check out Off the Radar.

Dr Diane Harper who headed the clinical trials for Gardasil is now speaking out and asking that vaccination is halted due to her concerns.  Read what she has to say on  www.offtheradar.co.nz

From AAFP News:
4/8/2009

Merck & Co. Inc. is launching two new programs for its quadrivalent human papillomavirus, or HPV, vaccine, in an attempt to take the uncertainty out of insurance coverage issues for patients and payment issues for physicians.
image

According to the CDC, early data indicate only about 10 percent of eligible, privately insured women ages 18-26 have received the first dose of the three-dose series for Merck’s HPV vaccine, which is sold as Gardasil.

Merck is obviously trying to increase sales without any regard for the many safety concerns that have been raised with regard to Gardasil.

Get Adobe Flash player